Meta-analysis of Efficacy of Topotecan

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This meta-analysis was conducted to investigate the efficacy of Topotecan and other treatments for recurrent and stage IVB carcinoma of the cervix

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Albumin-Bound Paclitaxel; Cisplatin; Paclitaxel; Topotecan

Criteria

Inclusion Criteria:

• Randomised Clinical Trials or systematic reviews or meta-analyses

• Treatment with topotecan or platinum-based single and combination regimens in female patients of any race with cancer of the cervix recurrent after radiotherapy or stage IVB disease

Exclusion Criteria:

• None